AEterna Zentaris Inc.

(AEZS) Trade

By |

Profile

AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline.

Contact Information

Website: www.zentaris.com
Email: ir@aezsinc.com
Main Phone: +1 843 900-3201
Address: 315 Sigma Drive
Address 2: Suite 302D
State: SC
City / Town: Summerville
Country: USA
Postal Code: 29486

Issuer Information

Exchange: NSC
CEO: Klaus Paulini
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline.

Contact Information

Website: www.zentaris.com
Email: ir@aezsinc.com
Main Phone: +1 843 900-3201
Address: 315 Sigma Drive
Address 2: Suite 302D
State: SC
City / Town: Summerville
Country: USA
Postal Code: 29486

Issuer Information

Exchange: NSC
CEO: Klaus Paulini
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 0.81 $ 0.0121 (1.51%)
Last Price 0.81 Change $ 0.0121 Change % 1.51 Tick N/A
Bid 0.79 Bid Size 2,300.00 Ask 0.87 Ask Size 400.00
Open 0.80 High 0.84 Low 0.80 Prev Close 0.80
Last Trade Volume 144,342 52 Wk Hi 5.58 52 Wk Low 0.81
Market Cap 16.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 20,031,610.00 EPS (TTM) -0.81 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3.5 3.5 3.5 3.5
Standard Deviation 0.71 0.71 0.71 0.71
Date of Most Recent Estimate 04/05/18 04/05/18 04/05/18 04/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1